About Research at BIDMC
The Forefront of "Bench to Bedside" Research
A prodigious and internationally respected enterprise, the Beth Israel Deaconess Medical Center fosters relationships among laboratory researchers and between basic science investigators and clinicians, accelerating work both in the labs and in the novel therapies we are able to bring to the bedside.
Amid a scientific climate in which revolutionary advances are occurring at an amazing pace - from the sequencing of the human genome to breakthrough discoveries in the molecular bases of common diseases and the creation of an almost unlimited number of sophisticated new technologies - BIDMC has successfully positioned itself to take full advantage of these opportunities.
Our extraordinary faculty has established a culture that is both entrepreneurial and collaborative, oriented toward translating new knowledge into novel medical treatments and patient care.
BIDMC Research at a Glance
- BIDMC investigators lead
more than 850 active sponsored projects and
more than 500 funded and non-funded clinical trials.
- Funding levels have steadily increased over the past 10 years and today, research at BIDMC is a
$200 million enterprise, funded by federal, corporate, foundation and internal donor sources, including 72 percent from federal grants.
- BIDMC consistently ranks in the
top four in National Institutes of Health (NIH) funding among independent hospitals nationwide.
- Research is led by
264 principal investigators who are Harvard Medical School faculty with BIDMC appointments in the medical center's 13 clinical departments.
- Studies by BIDMC
researchers are routinely published in the world's leading scientific journals, including
The New England Journal of Medicine.
Key areas of research at BIDMC include vascular biology, molecular imaging, transplantation, signal transduction, cancer biology, metabolic disease and obesity, neurobiology, AIDS, inflammation and cardiology/cardiac surgery.
Technology Ventures Office has earned a
national reputation for speeding the development of researchers' groundbreaking discoveries through collaborations with private industry.
The mission of Beth Israel Deaconess Medical Center is to be a world-class research institution where outstanding scientists work to develop new knowledge for the betterment of the health of our local and extended communities.
The research program strives to be renowned for its bench-to-bedside model of translational research, and for its collaboration with industry as a pathway for transferring the fruits of research into products that improve the quality of life.
We commit to maintain a collaborative culture and modern, high-quality facilities, and to take full advantage of the unique relationships that exist among the Harvard Medical School and the Harvard teaching hospitals.
- Establish an environment where
researchers & clinicians can effectively work together within & across organizational boundaries.
- Promote basic and translational research goals at the
Integrate major future recruitments into this emerging research strategic vision.
- Take advantage of a unique opportunity to
relocate and coordinate research facilities.
- Design and implement a series of
interdepartmental and interdisciplinary programs.
- Implement research governance that facilitates the
strategic development of research in an Academic Medical Center.